Biotechnology News reported by Medical Device News Magazine.
Vios Fertility Institute – St. Louis and TMRW Life Sciences Launches State-of-the-Art Cryo Management Technology for Fertility Specimens
TMRW’s technology provides the world’s first and only fully automated specimen management platform (CryoRobot) that identifies, tracks, and manages frozen eggs and embryos - central to almost every IVF journey. Vios Fertility Institute’s Chicago lab was the first in the world to adopt this revolutionary technology in early 2021.
Omeros received approximately $126 million in cash at closing. In addition, Omeros retains and is entitled to collect the full amount of its accounts receivable outstanding as of today’s closing.
The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-meter site of CAR-T Center.
This exciting product line will add new dimensions to Neoss existing Bone Regeneration offering, providing an enhanced offering of Bone materials and membranes.
Health Logic Interactive Announces Proof-of-Concept Test Results and Advancement of its Lab-on-Chip Technology
With these developments, Health Logic Interactive is preparing for its pre-submission meeting with the United States Food and Drug Administration.
This integration unlocks new antibody discovery workflows like performing structural analysis of proteins of interest and annotating important liability characteristics to select antibody candidates with good developability properties.